ReviewAnti-cancer agents in medicinal chemistry2012

Are KRAS/BRAF mutations potent prognostic and/or predictive biomarkers in colorectal cancers?

Tomoya YokotaPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.